KLK3 and prostate carcinoma: The clinical measurement of prostate-specific antigen density (PSA-D) is closely related to prostate volume (PV), and PSA-D serves as an indicator of prostate cancer (PCa), with higher PSA-D values suggesting a greater likelihood of clinically significant PCa (100–102).